These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10336228)

  • 1. Nefazodone for patients with chronic fatigue syndrome.
    Hickie I
    Aust N Z J Psychiatry; 1999 Apr; 33(2):278-80. PubMed ID: 10336228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic fatigue syndrome with nefazodone.
    Goodnick PJ; Jorge CM
    Am J Psychiatry; 1999 May; 156(5):797-8. PubMed ID: 10327922
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
    Manber R; Rush AJ; Thase ME; Amow B; Klein D; Trivedi MH; Korenstein SG; Markowitz JC; Dunner DL; Munsaka M; Borian FE; Martin ; Keller B
    Sleep; 2003 Mar; 26(2):130-6. PubMed ID: 12683470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder.
    Hertzberg MA; Feldman ME; Beckham JC; Moore SD; Davidson JR
    Ann Clin Psychiatry; 2002 Dec; 14(4):215-21. PubMed ID: 12630657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nefazodone therapy in patients with treatment-resistant or treatment-intolerant depression and high psychiatric comorbidity.
    Sajatovic M; DiGiovanni S; Fuller M; Belton J; DeVega E; Marqua S; Liebling D
    Clin Ther; 1999 Apr; 21(4):733-40. PubMed ID: 10363738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case study: nefazodone for juvenile mood disorders.
    Wilens TE; Spencer TJ; Biederman J; Schleifer D
    J Am Acad Child Adolesc Psychiatry; 1997 Apr; 36(4):481-5. PubMed ID: 9100422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
    Amsterdam JD; Shults J; Rutherford N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):100-6. PubMed ID: 17804135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nefazodone in primary insomnia: an open pilot study.
    Wiegand MH; Galanakis P; Schreiner R
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1071-8. PubMed ID: 15610919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The experience of sleep in chronic fatigue syndrome: A qualitative interview study with patients.
    Gotts ZM; Newton JL; Ellis JG; Deary V
    Br J Health Psychol; 2016 Feb; 21(1):71-92. PubMed ID: 25728396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.
    Schönfeldt-Lecuona C; Connemann BJ; Wolf RC; Braun M; Freudenmann RW
    Pharmacopsychiatry; 2006 Jul; 39(4):152-4. PubMed ID: 16871471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open trial of nefazodone in adult patients with generalized anxiety disorder.
    Hedges DW; Reimherr FW; Strong RE; Halls CH; Rust C
    Psychopharmacol Bull; 1996; 32(4):671-6. PubMed ID: 8993090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nefazodone decreases anxiety during marijuana withdrawal in humans.
    Haney M; Hart CL; Ward AS; Foltin RW
    Psychopharmacology (Berl); 2003 Jan; 165(2):157-65. PubMed ID: 12439626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA; Schweizer E; Rickels K
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
    McRae AL; Brady KT; Mellman TA; Sonne SC; Killeen TK; Timmerman MA; Bayles-Dazet W
    Depress Anxiety; 2004; 19(3):190-6. PubMed ID: 15129422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
    Schatzberg AF; Rush AJ; Arnow BA; Banks PL; Blalock JA; Borian FE; Howland R; Klein DN; Kocsis JH; Kornstein SG; Manber R; Markowitz JC; Miller I; Ninan PT; Rothbaum BO; Thase ME; Trivedi MH; Keller MB
    Arch Gen Psychiatry; 2005 May; 62(5):513-20. PubMed ID: 15867104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of somatization disorder with nefazodone: a prospective, open-label study.
    Menza M; Lauritano M; Allen L; Warman M; Ostella F; Hamer RM; Escobar J
    Ann Clin Psychiatry; 2001 Sep; 13(3):153-8. PubMed ID: 11791953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nefazodone in post-traumatic stress disorder: results from six open-label trials.
    Hidalgo R; Hertzberg MA; Mellman T; Petty F; Tucker P; Weisler R; Zisook S; Chen S; Churchill E; Davidson J
    Int Clin Psychopharmacol; 1999 Mar; 14(2):61-8. PubMed ID: 10220119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
    Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D
    Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.